share_log

Altamira Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.9%),Altium Growth Fund, LP EIN:(9.9%), etc.

SEC announcement ·  May 23, 2019 17:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more